| 5,940 | 276 | 304 |
| 下载次数 | 被引频次 | 阅读次数 |
对于多囊卵巢综合征(PCOS)相关不孕治疗及生育保护,目前国内外尚无公认的统一诊断标准,且治疗方案的选择也不尽相同。为使国内各级妇产科医师更好地诊治和管理PCOS相关不孕患者,更新知识,并与国际接轨,国内该领域的专家在参考国内外共识及文献、结合我国临床实践及具体情况,编写了"多囊卵巢综合征相关不孕治疗及生育保护共识",以提高临床医生对PCOS相关不孕治疗及生育保护的认识,达到规范诊断和治疗的目的。
Abstract：There is currently no generally-accepted criteria for infertility treatment and fertility protection related to polycystic ovary syndrome(PCOS),and the treatment protocols for these conditions are diversified. For enabling domestic obstetricians and gynecologists at all levels to better diagnose and manage infertile patients with PCOS,update their knowledge and integrate with international standards,Chinese experts in this field develop this expert consensus,based on the relevant Chinese and international guidelines and literatures,in order to improve clinicians' understanding of PCOS-related infertility treatment and fertility protection,and achieve the purpose of standardizing diagnosis and treatment.
[1] Azziz R,Carmina E,Dewailly D,et al.The androgen excess and PCOS society criteria for the polycystic ovary syndrome:the complete task force report[J].Fertil Steril,2009,91:456-488.
[2] Legro RS,Arslanian SA,Ehrmann DA,et al.Diagnosis and treatment of polycystic ovary syndrome:an Endocrine Society clinical practice guideline[J].J Clin Endocrinol Metab,2013,98:4565-4592.
[3] Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS)[J].Hum Reprod,2004,19:41-47.
[4] Teede HJ,Misso ML,Costello MF,et al.Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome[J].Fertil Steril,2018,110:364-379.
[5] 多囊卵巢综合征诊断中华人民共和国卫生行业标准[J].中华妇产科杂志,2012,47:74-75.
[6] Morgan ES,Wilson E,Watkins T,et al.Maternal obesity and venous thromboembolism[J].Int J Obstet Anesth,2012,21:253-263.
[7] 中国肥胖问题工作组中国成人超重和肥胖症预防与控制指南(节录)[J].营养学报,2004,26:1-4.
[8] Conway G,Dewailly D,Diamanti-Kandarakis E,et al.The polycystic ovary syndrome:a position statement from the European Society of Endocrinology[J].Eur J Endocrinol,2014,171:1-29.
[9] 贺媛,彭左旗,韩程成,等.低碳水化合物饮食对改善肥胖型多囊卵巢综合征患者不孕的临床研究[J].中国计划生育学杂志,2015,23:235-238.
[10] Spritzer PM,Poy M,Wiltgen D,et al.Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism:influence on LH and relationship with hormonal,metabolic,and anthropometric measurements[J].Hum Reprod,2001,16:1340-1346.
[11] 王永,张呈玲,刘翠英.肥胖与妊娠期及远期母儿并发症[J].中国计划生育学杂志,2018,26:1135-1136.
[12] Leary C,Leese HJ,Sturmey RG.Human embryos from overweight and obese women display phenotypic and metabolic abnormalities[J].Hum Reprod,2015,30:122-132.
[13] Morgan ES,Wilson E,Watkins T,et al.Maternal obesity and venous thromboembolism[J].Int J Obstet Anesth,2012,21:253-263.
[14] Wolfe KB,Rossi RA,Warshak CR.The effect of maternal obesity on the rate of failed induction of labor[J].Am J Obstet Gynecol,2011,205:128 e121-127.
[15] Carmina E,Lobo RA.Polycystic ovary syndrome(PCOS):arguably the most common endocrinopathy is associated with significant morbidity in women[J].J Clin Endocrinol Metab,1999,84:1897-1899.
[16] Venkatesan AM,Dunaif A,Corbould A.Insulin resistance in polycystic ovary syndrome:progress and paradoxes[J].Recent Prog Horm Res,2001,56:295-308.
[17] Cooney LG,Lee I,Sammel MD,et al.High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome:a systematic review and meta-analysis[J].Hum Reprod,2017,32:1075-1091.
[18] Veras AB,Bruno RV,de Avila MA,et al.Sexual dysfunction in patients with polycystic ovary syndrome:clinical and hormonal correlations[J].Compr Psychiatry,2011,52:486-489.
[19] Eftekhar T,Sohrabvand F,Zabandan N,et al.Sexual dysfunction in patients with polycystic ovary syndrome and its affected domains[J].Iran J Reprod Med,2014,12:539-546.
[20] Moran LJ,Hutchison SK,Norman RJ,et al.Lifestyle changes in women with polycystic ovary syndrome[DB/OL].Cochrane Database Syst Rev,2011,(3):CD007506.
[21] 中华医学会妇产科学分会内分泌学组及指南专家组多囊卵巢综合征中国诊疗指南[J].中华妇产科杂志,2018,53:2-6.
[22] Moran LJ,Noakes M,Clifton PM,et al.C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome[J].J Clin Endocrinol Metab,2007,92:2944-2951.
[23] 李央,李昕,林金芳.乙炔雌二醇/醋酸环丙孕酮联合生活方式调整对肥胖型多囊卵巢综合征生殖内分泌和糖脂代谢的影响[J].中国实用妇科与产科杂志,2007,23:481-483.
[24] Vause TDR,Cheung AP;SOGC Reproductive Endocrinology & Infertility Committee.Ovulation induction in polycystic ovary syndrome.SOGC Clinical Practice Guideline No.242,May 2010.J Obstet Gynaecol Can 2010;32:495-502[J].J Obstet Gynaecol Can,2011,33:12.
[25] Roque M,Tostes AC,Valle M,et al.Letrozole versus clomiphene citrate in polycystic ovary syndrome:systematic review and meta-analysis[J].Gynecol Endocrinol,2015,31:917-921.
[26] 李蓉,乔杰.生殖内分泌疾病诊断与治疗[M].北京:北京大学医学出版社,2013:115-135.
[27] 陈子江,刘嘉茵.多囊卵巢综合征-基础与临床[M].北京:人民卫生出版社,2009:203-206.
[28] Balen AH,Morley LC,Misso M,et al.The management of anovulatory infertility in women with polycystic ovary syndrome:an analysis of the evidence to support the development of global WHO guidance[J].Hum Reprod Update,2016,22:687-708.
[29] Kuivasaari-Pirinen P,Hippelainen M,Hakkarainen H,et al.Cumulative baby take-home rate among women with PCOS treated by IVF[J].Gynecol Endocrinol,2010,26:582-589.
[30] Kalra SK,Ratcliffe SJ,Dokras A.Is the fertile window extended in women with polycystic ovary syndrome?Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rate[J].Fertil Steril,2013,100:208-213.
[31] Kumar P,Nawani N,Malhotra N,et al.Assisted reproduction in polycystic ovarian disease:A multicentric trial in India[J].J Hum Reprod Sci,2013,6:49-53.
基本信息:
中图分类号:R711.6;R711.75
引用信息:
[1].多囊卵巢综合征相关不孕治疗及生育保护共识[J].生殖医学杂志,2020,29(07):843-851.